共 126 条
[1]
Hoyer D., Clarke D.E., Fozard J.R., Et al., International union of pharmacology classification or receptors for 5-hydroxytryptamine (serotonin), Pharmacol Rev, 46, 2, pp. 157-203, (1994)
[2]
Sternbach H., The serotonin syndrome, Am J Psychiatry, 148, (1991)
[3]
Kline S.S., Mauro L.S., Scala-Barnett D.M., Et al., Serotonin syndrome versus neuroleptic malignant syndrome a cause of death, Clin Pharm, 8, (1989)
[4]
Beasley C.M., Masica D.N., Heiligenstein J.H., Et al., Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings, J Clin Psychopharmacol, 13, (1993)
[5]
Neuvonen P.J., Pohjola-Sintonen S., Tacke U., Et al., Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses, Lancet, 342, (1993)
[6]
Palmer H., Potentiation of pethidine, BMJ, 2, (1960)
[7]
Reid N.C.R.W., Pethidine and phenelzine, BMJ, 1, (1962)
[8]
Rivers N., Horner B., Possible lethal reaction between nardil and dextromethorphan, Can Med Assoc J, 103, (1970)
[9]
Pope H.G., Jonas J.M., Hudson J.I., Et al., Toxic reaction to the combination of monoamine oxidase inhibitors and tryptophan, Am J Psychiatry, 142, (1985)
[10]
Shaie S.J., Barriga C., The hazards of use of monoamine oxidase inhibitors in disturbed adolescents, Can Med Assoc J, 104, (1971)